Ensemble Learning of Colorectal Cancer Survival Rates

Rates of colorectal cancer screening.

We recently reported that 23.5% of Canadians aged 50 years or older who were at average risk for colorectal cancer had ever received screening for colorectal cancer; this value fell to 17.6% when only up-to-date screening was considered. In the CMAJ editorial published with our study, Alan Barkun and Ken Flegel reported that 62.9% of patients in the United States were screened. Roy Preshaw subs...

Effects of CD133 Silencing on Survival and Migration of HT-29 Colorectal Cancer Cells

Background: Colorectal cancer (CRC) is attributed as one of the most common malignancies worldwide. CD133 molecule, as a pentaspan transmembrane glycoprotein, confers stem cell-related characteristics, including self-renewal and multi-directional differentiation capability. CD133 plays important roles in the progression of CRC by conferring apoptotic resistance and migration ab...

Interpreting cancer survival rates.

Does ethnicity affect survival following colorectal cancer? A prospective, cohort study using Iranian cancer registry

  Background:The present study compared the differences between survivals of patients with colorectal cancer according to their ethnicity adjusted for other predictors of survival.   Methods: In this prospective cohort study patients were followed up from definite diagnosis of colorectal cancer to death. Totally, 2431 person-year follow-ups were undertaken for 1127 colorectal cancer patients on...

An Ensemble Prognostic Model for Colorectal Cancer

Colorectal cancer can be grouped into Dukes A, B, C, and D stages based on its developments. Generally speaking, more advanced patients have poorer prognosis. To integrate progression stage prediction systems with recurrence prediction systems, we proposed an ensemble prognostic model for colorectal cancer. In this model, each patient was assigned a most possible stage and a most possible recur...